Dr. Michael Fakih is Reproductive Endocrinologist and Infertility Consultant with over 30 years of experience. He is recognized as a leader in the field of assisted reproduction and is responsible for over 12,000 IVF deliveries. His continuous efforts in innovation of new techniques has made him a pioneer in his field. He has been listed in 2008 as one of the top 15 American Lebanese of all time in the category of Medicine. Dr. Fakih is the Medical Director of Fakih IVF, UAE, IVF Michigan, USA, and Founder of FIRST IVF, Lebanon. In addition, he is Associate Professor at Michigan State University, College of Human Medicine.
Head of the Reproductive Medicine Unit - Jean Verdier Hospital - Bondy - University Paris XIII Professor in Biology & Medicine of Development and Reproduction - University Paris XIII Ph.D. in Biochemistry & Biology of Reproduction - University Paris XI Member of the French, European and American societies of Reproductive Medicine
MD,PhD,Assistant Professor at the Russian Medical Academy for Postgraduate Education, Centre for Reproductive Medicine “Life line”, Moscow, Russia
Julia Koloda is an assistant professor at the Russian Medical Academy for Postgraduate Education, Department of Obstetrics, Gynecology, and Medical Doctor, a specialist in reproductive endocrinology and IVF at the Centre for Reproductive Medicine “Life line”
She completed her medical training in Moscow Medical Academy named after I.M. Sechenov and residency training in Russian Medical Academy for Postgraduate Education. During the period she had 4 months training in IVF unit at the Ludwig-Maximilians-University of Munich headed by Prof.Marcus S.Kupka,past chairman of the European IVF Monitoring (EIM) Consortium.
Co-author and author of more than 50 publications (articles in journals, monographs, practical guidelines) She is also intensively involved into editorial activity being an Executive Editor of Russian Journal of Human Reproduction.
Dr Ayman Al-Hendy is currently a Professor (Tenure) and Director, Division of Translational Research, Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta University (formerly Georgia Regents University) Augusta, Georgia. He also serves as Director of Interdisciplinary Translational Research, Augusta University and Assistant Dean for Global Translational Research, Medical College of Georgia, Augusta University. Dr. Al-Hendy is a Gynecologist and Endoscopic Surgeon at Augusta University Medical Center, Augusta, Georgia with a busy practice that focuses on serving women with symptomatic uterine fibroids. Dr. Al-Hendy graduated from Banha Faculty of Medicine, Zagazig University, Banha, Egypt in 1986. After 1 year of internship at Banha University Hospital, he headed to Finland to earn his PhD in Molecular Medicine from University of Turku, Turku, Finland. He then gained additional postdoctoral training in gene therapy and clinical molecular genetics at McMaster University and McGill University in Canada, before completing clinical residency training in Obstetrics and Gynecology at University of Saskatchewan and fellowship training in laparoscopic surgery at Toronto University, both in Canada. Dr. Al-Hendy is double board certified by the Royal College of Surgeons of Canada and The American Board of Obstetrics and Gynecology. In United States of America, Dr. Al-Hendy held various faculty positions at University of Texas Medical Branch, Galveston, Texas, & Meharry Medical College, Vanderbilt University, Nashville, Tennessee before moving to Augusta, Georgia. Dr. Al-Hendy utilizes the methods of basic, translational and clinical research to address important medical diseases. Dr. Al-Hendy medical research interests focus on developing novel therapies including gene and stem cell therapy for Premature Ovarian Failure, Endometriosis, and particularly Uterine Fibroids. He is currently researching the utility of various nutritional supplements as possible non-surgical therapy for uterine fibroids which impact negatively women health worldwide and burden resources through the high rate of Hysterectomy especially in women of color. Recently, Dr. Al-Hendy isolated and characterized surface marker specific stem cells from human and rat fibroid lesions as well as adjacent at risk myometrium and normal myometrium and is utilizing these valuable tools to understand the role of developmental epigenetic re-programming and early life adverse environmental exposures in adult onset of uterine fibroids especially in women of color. In 2010, Dr. Al-Hendy was awarded the American Society of Reproductive Medicine’s (ASRM) 2010 Ira and Ester Rosenwaks Award for his significant contribution to the field of translational Reproductive Biology. In 2014 he received the alpha Omega alpha clinician scientist of the year award by the Medical Honor Society and in 2015 the President Achievement Award as well as Rogerio A. Lobo Award by the Society of reproductive Investigations (SRI). Dr. Al-Hendy research is funded by various agencies including NICHD, NIEHS, NIMHD, ODS, NCRR, USDA, and other national and international organizations. He has served as Chair of the NIH Integrative Clinical Endocrinology and Reproduction (ICER) IRG 2013-2015 and also serves on numerous other committees with organizations such NIH, ASRM, SRI and as Editor of The SRI 1st Alert as well as on several editorial boards of high impact Reproductive Biology journals. Dr. Al-Hendy has published more than 160 peer reviewed publications in high tier peer reviewed scientific journals, above 240 presentations in national and international meetings, and has edited 5 medical books.
Professor Mohamed Aboulghar is Professor of Obstetrics and Gynecology, Faculty of Medicine, Cairo University. He is the founder and Clinical Director of the Egyptian IVF Center, the first center in Egypt. He founded the Middle East Fertility Society (MEFS) and he is also the Editor-in-Chief and founder of the: Middle East Fertility Society Journal (since 1996). He is a member of numerous scientific committees of different international and regional societies all over the world, as well as editorial boards of many important journals including Fertility and Sterility. Dr. Aboulghar received the Egyptian National Award for Scientific Excellence in 1999. He also received the Honorary membership of the European Society for Human Reproduction and Embryology (ESHRE) in 2004 and Honorary membership of the International Federation of Fertility Societies (IFFS) in 2000.
Dr. Hotaling is a fellowship-trained urologist specializing in Male Infertility and Men’s Health. He completed his undergraduate work at Dartmouth, graduating magna cum laude with a double major in history and biophysical chemistry. He then went to Duke for medical school and completed a 6-year residency at the University of Washington, where he trained with one of the top penile reconstructive surgeons in the world, Dr. Hunter Wessells. There, he had extensive training in Erectile Dysfunction, Peyronie’s Disease and Male Infertility. Dr. Hotaling elected to pursue an additional year of training under Dr. Craig Niederberger at the University of Illinois at Chicago focusing on Male Infertility and Men’s Health. Here, he had extensive training in micro-surgery, including Testicular Sperm Extractions (TESE), Micro-dissection Testicular Sperm Extraction (microTESE), and Vasectomy Reversal. He is also one of the only Men’s Health and Infertility experts in the United States to have undergone additional training to become a Fellow of European College of Sexual Medicine (FECSM).
Dr. Hotaling research interests in the genetic and epigenetic determinants of Infertility and Erectile Dysfunction, the impact of Male Infertility on individual and familial somatic health and microfluidic sperm sorting. He has over 85 publications, numerous book chapters and speaks regularly on these topics at national and international meetings. Dr. Hotaling obtained an MS in clinical epidemiology at the University of Washington and focused on applying the tools of statistical genetics to Erectile Dysfunction.
Since joining the University of Utah, he has been continuously funded by the NIH/NSF. Dr. Hotaling serves as a principal investigator (PI) on an R01 to study the genetics of Erectile Dysfunction and an NSF SSTR Phase I grant to examine microfluidic sperm sorting. He is also a Co-investigator (co-I) on two other R01s examining the trans-generational effects of smoking and the largest study in the world on the genetics of Male Infertility. Additional funding stems from being a co-investigator on two large NICHD sponsored trials of Male Fertility, FAZST, the largest randomized controlled trial of Male Infertility ever performed and IDEAL, which examines the impact of pre-conception health on fertility. He has also cofounded three companies in the Men’s Health/Male Infertility space and won multiple national awards for research.
His work on Male Infertility has centered on establishing a tissue bank of testicular tissue which now contains over 300 specimens as well as building a large (>50,000 infertile individuals linked to >500,000 relatives) infertility database through the Utah Population Database called SHARE: subfertility health assisted reproduction and the environment. SHARE is the largest repository of epidemiologic and pedigree based information on male infertility in the United States and, likely, the world. Multiple publications from this database have helped elucidate the impact of Male Infertility on individual and familial somatic health. Additionally, he has played an integral role in complex translational genetic and epigenetic work that has sought to identify the causes of Male Infertility with a long-term goal of developing genetic and epigenetic markers for Male Infertility that will eventually lead to novel therapeutics for this devastating condition.
Prof. Dahdouh is the Founder and Medical Director of the Assisted Reproduction Center at the “Centre Hospitalier Universitaire (CHU) Sainte-‐‑Justine” in Montreal, Canada. He is board certified in both Reproductive Endocrinology and Infertility and Obstetrics and Gynecology in Canada. He is an Assistant Professor in the division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology at the University of Montreal. In addition, he is a member of the ART Committee in the College of Physicians of Quebec, and an Associate Member and Reproductive Endocrinologist at Procrea Clinics in Montreal, Canada. Elias received his M.D. from Saint-‐‑Joseph University in Beirut, Lebanon (1997), completed his residency in Obstetrics and Gynecology at the University of Montreal (2003), and underwent a Reproductive Endocrinology and Infertility fellowship training at Procrea Clinics Montreal, Canada (2008-‐‑2009). Following his training at IVI-‐‑Madrid, Spain (2009 and 2013) under the supervision of Prof. Juan Antonio García-‐‑Velasco, and at RBA-‐‑Atlanta, USA (2012) under the supervision of Prof. Zsolt Peter Nagy, his main research interests have been preimplantation genetic testing, recurrent pregnancy loss, fertility preservation for cancer patients, elective single embryo transfer, and the use of GnRH-‐‑ antagonists in IVF cycles. In addition, he obtained a Master Degree in Human Assisted Reproduction and Clinical Embryology from University Institute IVI Valencia (2014). Prof. Dahdouh has numerous publications in peer-‐‑reviewed journals. He authored the Society of Obstetricians and Gynecologists of Canada (SOGC) guidelines on Preimplantation Genetic Diagnosis and Screening. In fact, he is one of the most cited in the field of Preimplantation Genetics in the last 2 years. He has been invited as a guest speaker at multiple national and international scientific meetings. In November 2017, he was awarded by the Lebanese Society of Obstetrics and Gynecology
Robert W. Rebar, M.D., is currently Professor and Chair of Obstetrics and Gynecology at the new Western Michigan University Homer Stryker M.D. School of Medicine in Kalamazoo. Dr. Rebar is certified by the American Board of Obstetrics and Gynecology in obstetrics and gynecology and in reproductive endocrinology and infertility. He has had a long career in academic medicine, with faculty appointments at five different medical schools.
Dr. Rebar received his M.D. degree from the University of Michigan in 1972 and from 1972 to 1974 was a resident in obstetrics and gynecology at Parkland Memorial Hospital in Dallas, Texas. He was a Clinical Associate in the Reproduction Research Branch of the National Institute of Child Health and Human Development (1974-1976) before completing his residency in Obstetrics and Gynecology at the University of California at San Diego Medical Center (1976-1978). After his residency, Dr. Rebar continued on at the University of California, San Diego for six years (1978-1984), serving as Associate Professor and Director of the Division of Reproductive Endocrinology for the last two of those years. He was Professor and Head of the Division of Reproductive Endocrinology and Infertility in the Department of Obstetrics and Gynecology at the Northwestern University School of Medicine (1984-1988). Dr. Rebar then was Professor and Chairman of the Department of Obstetrics and Gynecology at the University of Cincinnati College of Medicine from 1988 through 1999 and served as Associate Executive Director of the American Society for Reproductive Medicine (ASRM) from 2000 through 2002. He then served as Executive Director of the ASRM from 2003 through 2013 before retiring and moving to Michigan.
Dr. Rebar is a member of numerous professional societies, including the American College of Obstetricians and Gynecologists (Fellow), the American Gynecological and Obstetrical Society, the Endocrine Society, and the Society for the Study of Reproduction. Dr. Rebar has served on the editorial boards of several journals and is currently a Deputy Editor for the journal Contraception and an Associate Editor for Journal Watch Women’s Health and OB/GYN Clinical Alert. Dr. Rebar has contributed to many books, as well as authored over 250 articles on menopause, fertility, and reproductive endocrinology and has been the Principal or a Co-Investigator on several NIH grants.
Dr. William Catherino is a Reproductive Endocrinologist and Infertility specialist who practices at both the National Institutes of Health and Walter Reed National Military Medical Center. He is responsible for participating in the largest IVF program in the Department of Defense. He has been Board Certified for over 10 years, writes questions for the written Boards, and is an Oral Boards Examiner.
Dr. Catherino is also a tenured Professor who teaches at the Uniformed Services University of the Health Sciences, and is the Principal Investigator of his laboratory where he studies uterine fibroids. In this role, he has developed novel models to study human uterine fibroids, resulting in well over 50 peer-reviewed publications (of over 100 total peer-reviewed manuscripts) and over 100 international presentations. He has received research support from the National Institutes of Health, as well as from various Foundations and private courses.
Finally, Dr. Catherino has Chaired multiple Post-Graduate courses at the American Society for Reproductive Medicine and the Society for Reproductive Medicine, and has been Chair of the Fibroid Special Interest Group.
Dr. Atsushi Tanaka is the director of Saint Mother Hospital, located in Kita-Kyushu City, Japan. He obtained his postgraduate degree from the Department of Obstetrics and Gynecology of Juntendo University. He established Saint Mother Hospital in 1990, which has since become one of the premier fertility clinics in Japan and now has 8000 ART cycles yearly. He has a long-standing interest in the scientific aspects of reproductive medicine, biology and spermatogenesis. He served as an expert member of scientific committee, Ministry of Health, Labor and Welfare (from 1998 to 2000). He is a vice-president of the Japan Society of Fertilization and Implantation and he organized the annual congress of the society as a chairman in 2008. He was a president of Japanese Institution for Standardizing Assisted Reproductive Technology (2009-2011), and a councilor of the Japan Society for Reproductive Medicine and the Japanese Society of Mammalian Ova Research. He won the ASRM star award 2015 in October 2015 and became a member of ASPIRE board in April 2016.
With over 28 years of experience, Dr. Rupin Shah is a well-known, internationally recognized expert in the field of Male Infertility and Sexual Dysfunction with specialty in Sperm Mapping, needle aspiration TESA and micro-dissection TESE procedures. He is the pioneer of male reproductive microsurgery in India and is the developer of the first Indian Penile Prosthesis. Dr. Rupin has been actively involved in teaching for 20 years and has published over 100 articles and chapters on Male Sexual Dysfunction and Male Infertility.
Membership: Member of the Editorial Committee of the Indian Journal of Urology 1995-1998, Hon. Visiting Andrologist at Institute for Research in Reproduction (Indian Counsel for Medical Research), Peer Review Panel of the Journal of Obstetrics and Gynecology of India.
Education: Dr. Rupin received his M.B.B.S. from Bombay University with 1st Rank, Distinction in Surgery. He went on to receive an M.S. in General Surgery and an M.Ch in Urology, also from Bombay University.
Awards: Dr. Rupin has received over 20 prestigious awards for his work in this field, including the DR B C Roy award from the President of India in 2008, granted for developing Andrology as a super-specialty in India.
Dr. Heather Gibson Huddleston is an Associate Professor of Reproductive Endocrinology and Infertility (REI) at the University of California-San Francisco (UCSF). She received her medical degree at Harvard Medical School and then completed her residency training in Obstetrics and Gynecology and fellowship training in REI at the Harvard/Brigham and Womens Hospital. Dr. Huddleston has published over 45 research articles and has a research interest in Polycystic Ovary Syndrome (PCOS). She directs the Multi-Disciplinary Clinic for PCOS at UCSF and leads multiple studies that investigate aspects of this disorder, including lifestyle strategies, aging and depression. In addition, Dr. Huddleston directs the oocyte donation program and oocyte donor cryobank at UCSF.
Dr. Amal Al-Shunnar is an Emirati Consultant IVF, OB/GYN and co-founder of Fakih IVF with over 20 years of experience in her field. After completing her training in IVF and Infertility in the UK and Ireland, Dr. Al-Shunnar returned to the UAE and worked in the Obstetrics and Gynecology department of Al Wasl Hospital before joining her family's practice, Al Shunnar Polyclinic in 2003 as a Consultant IVF, OB/GYN. At this time, she also began working with Dr. Michael Fakih at Dr. Fakih Gynecology and Obstetrics Center before they together opened Fakih IVF Dubai in 2011.
Membership: Membership of the Royal College of Obstetricians and Gynecologists.
Education: Dr. Amal obtained her Medical Degree from the Royal College of Surgeons in Ireland and trained in some of the most prestigious medical hospitals in Europe, the Hammersmith Hospital in London and Rotunda Hospital in Dublin. After obtaining her Membership of the Royal College of Obstetricians and Gynecologists (MRCOG), she completed her fellowship in Reproductive Endocrinology in London and is certified in Advanced Gynecological Endoscopy.
Dr. Alpesh is a consultant Clinical Embryologist and a co-founder at London Fertility Institute. He is also a co-founder and director of the Embryology and PGD Academy. Alpesh previously worked at the CRGH in the leading capacity as a Director of Embryology for 19 years and was pivotal in optimising the success rates. He was also an honorary consultant at the Reproductive Medicine Unit at UCLH NHS Trust. He holds a postgraduate degree in Human Reproductive Medicine and has qualified from the prestigious Imperial College school of Medicine. Alpesh is a Diplomate of the Royal college of Pathologists and also a Eshre certified Senior Embryologist. He has been an executive committee member of several International embryology societies and holds a very active interest in promoting education platforms through these professional bodies. He was among the first scientists to bring the egg freezing technology of 'Vitrification' to the UK in 2007. He is a world renowned expert in the biopsy of human embryos for genetic testing. Alpesh has authored several papers in high impact journals and written several book chapters in addition to being a lecturer at University College London where he teaches embryology on two of the Masters courses. He has been an invited speaker in many International conferences and workshops as well as several Health chat shows on television including Zee TV and ITV's This morning. Alpesh has a special interest in Fertility preservation, Preimplantation Genetic Diagnosis and genome editing of embryos.
Fady I. Sharara, M.D, FACOG, is a Board Certified Reproductive Endocrinologist/Infertility specialist, and a Board Certified Obstetrician/Gynecologist. Dr Sharara is the founder and Medical Director for the Virginia Center for Reproductive Medicine (VCRM) in Reston, VA and is a Clinical professor in the dept of OB/GYN at George Washington University in Washington, DC. Dr Sharara has published more than 70 scientific papers and book chapters. He is the editor of “Ethnic Differences in Fertility and Assisted Reproduction” published in 2013.
Dr. Jones is Professor Emerita in the Department of Obstetrics and Gynecology where she has had an academic appointment for the 33 years. Her undergraduate degree was in Molecular, Cellular and Developmental Biology from the University of Colorado, where she also attended Medical School. Her residency in obstetrics and gynecology and her fellowship in reproductive endocrinology were completed at the Brigham and Women’s Hospital, Harvard Medical School.
Her clinical and research interests include contraception and family planning, advanced reproductive technology, and menopause. She has been a member of the National Medical Committee for Planned Parenthood and is past Chair of the Association of Reproductive Professionals. She has taught Ethics in Reproductive Medicine in the Honors Program at the University of Utah, as well as teaching reproductive medicine to medical students, residents and physicians. She was awarded the Linda K Amos Award for Distinguished Service to Women by the University of Utah, and the Jarcho Distinguished Teaching Award by the University of Utah School of Medicine. In 2013 she was awarded the Calvin and Jeneal Hatch Prize in Teaching by the University of Utah. She has been involved in the administration of her department, medical school, and university and has a certificate in Alternative Dispute Resolution from the University of Utah. She is a past President of the Academic Senate at the University of Utah.
Dr. Sue Hammoud is an Assistant Professor at University of Michigan in the Department of Human Genetics. Dr. Hammoud received her Ph.D. at the University of Utah. As a postdoctoral Helen Hay Whitney fellow she has explored how chromatin regulates germline stem cell development and tissue homeostasis. Currently, Dr. Hammoud’s lab – a recipient of the NIH innovator award - is investigating the cellular and genetic factors required to make a healthy and developmentally competent gamete.
Dr. Monikaa Chawla is a Reproductive endocrinologist and fertility specialist practicing the subspecialty for more than 20 years.
Education: She completed her MD in 1998 and was awarded the membership of the Royal College of Obstetricians and Gynecologists (MRCOG) in 2004. She went on to complete her fellowship in Reproductive medicine at the prestigious Guy And St. Thomas Hospital in London which is also the pioneer center for Pre-Implantation Diagnosis (PGD) in the UK. She was awarded the Fellowship of the Royal College of Obstetricians and Gynaecologists (FRCOG) in 2016 .
She completed her postgraduate award in Assisted Reproduction from Warwick University ,UK with thesis on 'Time lapse technology and its current implications'. Her current publications and research work is focused on recurrent Implantation failures and time-lapse morphokinetics with preimplantation genetic screening . She is a Masters in Human Embryology and Biotechnology from IVI , Valencia , Spain .
Dr. Monika is also highly specialized in minimal access surgery (Laparoscopy and Hysteroscopy, diagnostic and operative) having trained at the Royal Free Hospital in London and Kiel University in Germany. Her research work has been published in 27 international and indexed journals and has presented at various international conferences.
Membership: A member of the American Society of Reproductive Medicine, the British Fertility Society and the American Association of Gynecology Laparoscopists.
Awards: Received Overseas Travel Fellowship through the Royal College Of Obstetricians and Gynecologists, August 2003Languages Spoken: Basic Arabic, English, Hindi, Urdu
Originally from Barcelona, Dr. Munné gained his Ph.D. in Genetics from the University of Pittsburgh and in 1991, joined Dr. Jacques Cohen at the Cornell University Medical College located in New York City. It was at Cornell, he developed the first Preimplantation Genetic Screening (PGS) test to detect chromosome abnormalities, which resulted in the first PGS babies in 1993, for which he received prizes in 1994 and 1995 by The Society for Assisted Reproductive Technology (SART).
Dr. Munné became the Director of Preimplantation Genetic Diagnosis at The Institute for Reproductive Medicine and Science of Saint Barnabas in 1995 where he developed the first test to detect chromosome translocations in human embryos obtaining the SART prize for it in 1996, as well as demonstrating a significant decrease in spontaneous abortions after PGS, which obtained the 1998 prize paper of the Society for Assisted Reproductive Technology. His team and collaborators were the first to suggest and demonstrate higher implantation rates, lower rates of spontaneous abortions as well as trisomic offspring after PGS.
In 2001, Dr. Munné co-founded Reprogenetics, with Jacques Cohen and David Sable. He directed the company until 2016 and saw its expansion to four continents. Reprogenetics was the first commercial lab to offer PGS and PGD and was the market leader until it was sold to in 2015 to Cooper Companies (NYSE: COO). During this time Reprogenetics performed over 70,000 PGD cycles globally. Reprogenetics stayed in the forefront of research and development focusing in the use of comprehensive genetic analysis of embryos in order to improve pregnancy outcomes and diminish the risk of miscarriages in gene and chromosome inherited disorders. Munne and co-researchers were rewarded with SART prize papers in 2005, 2015 and 2016, and he has received The American Society for Reproductive Medicine Star Award consecutively for the years 2011-2016.
In 2011 Dr. Munné co-founded with Alex Bisignano the genomics company, Recombine. It’s first test, CarrierMap screened for over 300 gene defects, allowing carrier couples to conceive unaffected children through PGD testing. Some of the assets of this company were sold in 2016 to Cooper Companies (NYSE: COO), and the rest were spun off into another genomics company, Phosphorous, also founded by Dr. Munné and Alex Bisignano. This company is developing FertilityMap, which aims to improve fertility outcomes by applying machine learning and genomics using “big data” generated through IVF records and patient sequencing. In addition, in 2017 Co-Founded Dr. Munné co-founded MedAnswers with CEO Alice Crisci, a digital health platform for the infertility field, connecting patients with specialists. In addition of Phosphorus and MedAnswers he is in the board of advisors of Previvo.
Dr. Munné’s research interests is on the prevention of genetic disease and infertility through pre-implantation testing of embryos and couples, understanding the impact of chromosome abnormalities in human reproduction, and developing personalized genetic tests for infertility and other conditions. Current projects are to determine how to reduce chromosome abnormalities by changing assisted reproductive methods, detection of de novo mutations in embryos inducing autism and other disorders and non invasive methods of testing embryos. Dr. Munné has published over 230 peer-reviewed scientific publications, and is a frequent lecturer, both nationally and internationally. He is co-founder (2002) and member of the Board of Directors of the Preimplantation Genetic Diagnosis International Society (PGDIS) and served as president and other board of directors positions from 2002-2014.
With the purchase by CooperSurgical of Reprogenetics, Recombine and Genesis Genetics, in 10/2016 Dr. Munné’s became the Chief Scientific Officer of CooperGenomics.
Dr. Hussein Kandil, a new member to Fakih IVF family joins from Lebanon. Dr. Kandil is a urologist specializing in male reproductive and sexual medicine, graduated from the division of urology at St. George Hospital University Medical Centre, in affiliation with Balamand university, Lebanon.
He completed his residency at the division of urology at Pontoise regional hospital and Lens university hospital in France, and earned his Diploma in Urology in 2008.
After completing his residency in 2009, he joined the division of urology of the University of Illinois at Chicago for a Fellowship in Andrology, which is the field of urology that specializes in the management of male infertility and sexual dysfunction.
In 2017, Dr. Hussein Kandil earned the Fellowship of the American College of Surgeons, and received the title FACS.
Over the recent years, Dr. Kandil has become a known figure in the field of male reproductive medicine namely, male infertility and sexual dysfunction and has been an active contributor and a participant to different medical societies presenting many conferences at the national and international levels, sharing his expertise in the realm of male reproductive medicine.
His area of interest lies in is utilization of microsurgery in the surgical management of male infertility, e.g Microdissection Testicular Sperm Extraction, also known as MTESE in the management of Non- Obstructive Azoospermia, and has special interest in male reproductive endocrine disorders.
Dr. Kandil expertise encompasses the medical and surgical treatment of the various prostate diseases including laser therapy for enlarged prostate glands, in addition to the medical and surgical management of sexual dysfunction.
In addition to physical consultations, Dr. Kandil has an active online presence, having created an online blog called ‘Your Male Doctor Blog’, with over 14 thousand viewers and participants. www.yourmaledoctor.com
Dr. Kandil has authored and published on amazon a public manual in English and Arabic, called ‘The Male: Pearls of Hope in Male Infertility’, which is a manual that guides males through their journey of male infertility.
Dr Hammoud is a Reproductive Endocrinology and Infertility specialist. He received his medical degree from Saint Joseph University. He finished his residency in Obstetrics and Gynecology at Wayne State University in Michigan. In 2005, Dr. Hammoud completed a fellowship in Reproductive Endocrinology and Infertility at the University of Utah in Salt Lake City where he stayed on faculty for 6 years as an assistant professor. He currently serves as the Medical director of IVF Michigan in Bloomfield hill, Michigan, USA. Dr Hammoud received multiple local and national awards for excellence in clinical care, medical education and infertility research. His professional interests include effect of environment and diet on fertility, abnormal sperm testing, and In Vitro Fertilization (IVF).
Consultant in Obstetrics & Gynecology- Specialist in advanced Minimally Invasive Surgery
Head of Women’s Health Directorate at Al Zahra private hospital- Dubai (AZHD)
President of the Emirates Endometriosis League-EMEL
Languages spoken: Arabic, English, Swedish, Norwegian, Finnish, Russian.
Dr. Ghassan started his practice as an obstetrician/gynecologist in Scandinavia in 1990, after publishing his post-medical fellowship thesis on “Hormonal receptors in endometrial cancer” in 1989 in Sankt-Petersburg.
Within 20 years of service in Scandinavian countries, Dr. Ghassan received the Swedish board in OB/GYN in 1998, followed by the Finnish and Norwegian OB/GYN board in 1999 and 2000 respectively, working as head of department in Finnish regional hospitals, and consultant in the university hospitals of Ulleval (Oslo), Soder and Karolinska (Stockholm).
Since 2010, Dr. Ghassan has been working in private and public hospitals in the U.A.E., where he helped build service of excellence in minimally invasive surgery in the DHA, and got it accredited from the American Association of Gynecologic Laparoscopy- SRC/ AAGL.
Dr. Ghassan is the current president of the Emirates Endometriosis League, and has special interest in endometriosis and problems of chronic pelvic pain.
Besides skills in advanced endoscopic surgery, Dr. Ghassan has extensive experience in dealing with high risk pregnancies and pregnancy-related pathologies while working in obstetric tertiary centers in Scandinavia and Dubai.
Dr. Ghassan is Swedish/ Finnish citizen and from Lebanese origin. Swimming, music and travel are some of his hobbies. He is married and has four children.
Miss Gaëlle Russias is currently in charge of the commercialization of the RGH products portfolio of Illumina for France, Netherlands and Belgium. She is holding a M.Sc. degree in Molecular and Cellular Biology followed by 1 year business school program. Gaëlle Russias has 13 years' experience in Life Science industry holding several positions in sales and marketing securing the launch of a variety of technologies such as, Advanced Analytical Technologies, BioDiscovery and Sequenom.
More recently she moved to BlueGnome, a company specialized in developing innovative genetics tools for PGS and PGD who got acquired by Illumina in 2012. Miss Russias has an extensive knowledge in the Reproductive Genetic Health market and has been directly involved in recent adoption of NIPT in large national project like in Netherlands, Belgium and France.
Hugh S. Taylor, M.D., is the Anita O'Keeffe Young Professor of Women's Health and chair of the Department of Obstetrics, Gynecology and Reproductive Science, at the Yale School of Medicine in New Haven, Connecticut. He is also Professor of Molecular, Cellular and Developmental Biology at Yale University. He is a board-certified specialist in Obstetrics/Gynecology and in Reproductive Endocrinology. Dr. Taylor received his undergraduate training at Yale University and received his medical degree from the University of Connecticut School of Medicine. He completed his residency in Obstetrics and Gynecology at Yale. His postdoctoral training included a fellowship in Reproductive Endocrinology and Infertility as well as a fellowship in Molecular Biology, both at Yale.
Dr. Taylor is a recipient of eight National Institutes of Health research grants and directs The Yale Center for Reproductive Biology. His clinical research centers on implantation, endometriosis and menopause. His basic science research focuses on uterine development, the regulation of developmental gene expression by sex steroids, endocrine disruption and on stem cells. Dr. Taylor has published more than 300 articles in leading medical journals. He is the Editor-In-Chief of Reproductive Sciences and an editor of Endocrinology.
He serves on several editorial boards and as a reviewer for numerous scientific journals and is frequently invited as a speaker at national and international medical meetings. Dr. Taylor has received numerous awards including the IVI Foundation International Award for the Best Research in Reproductive Medicine and the Society for Gynecologic Investigation President Achievement Award. He has also served as the academic mentor of numerous trainees and has twelve times been awarded the Society of Gynecologic Investigation President Presenter's Award for this training. Dr. Taylor is past president of the Society for Reproductive Investigation, and was on the Board of Directors of The American Society for Reproductive Medicine, Environment & Human Health, and the International Institute of Primate Research. He was elected to the National Academy of Medicine in 2016.
Zeynep Alpay Savasan, MD is a Maternal Fetal Medicine specialist practicing at Oakland University Beaumont Health System, Department of Obstetrics and Gynecology in Michigan, USA. She had her Obstetrics and Gynecology residency training at Wayne State University followed by Maternal Fetal Medicine fellowship at NICH/NIH the Perinatology Research Branch, Detroit, Michigan. She had Reproductive Endocrinology and Infertility (REI) training followed by several years of clinical practice and research experience in Turkey before settling in USA.
She has expertise in preconception counseling and management of high-risk pregnancies. She has several publications on pathophysiology and immunology of preterm labor, preeclampsia and pregnancy loss. She is running a specialized clinic on recurrent pregnancy loss in Michigan, USA. This is a multispecialty clinic collaborating with REI and related specialists. Her research interest is focused on understanding the pathophysiology of recurrent pregnancy loss and therapy options.
Dr. Sharp has been a faculty member in the Department of Obstetrics and Gynecology at the University of Utah School of Medicine since 1995, and is currently a professor with tenure, serving as Vice Chair for Clinical Activities and Quality, and as Chief of the General Division. He has had a career-long interest in chronic pelvic pain and is currently the Director of the Utah Women’s Chronic Pelvic Pain Clinic, part of a multidisciplinary pain clinic at the University of Utah Medical Center, and served as the President of International Pelvic pain Society from 2008-2009.
His research interests also include gynecologic surgery and surgical complications and he has been a course director for the postgraduate course on surgical complications at ACOG’s Annual Clinical Meeting from 2006 to 2017. He is a Section Editor for Gynecologic Surgery for Up-to-Date, and has been Chair of the FDA Device panel for gynecology, Chair of the Practice Bulletin Committee – Gynecology (ACOG), Chair of Clinical Document Review – Gynecology (ACOG), and Co-Chair of ACOG’s ReVitalize Program.